Susquehanna Portfolio Strategies, LLC

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1996449 Bala Cynwyd, PA

Back to AMRX Full portfolio

Position in AMRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,077,077

-$55,760 QoQ

Shares Held

328,003

0.0% QoQ

Ownership

0.103%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Susquehanna Portfolio Strategies, LLC holds $45,181,359 across 9 Drug Manufacturers - Specialty & Generic names. AMRX ranks #3 (9.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	184,035	$24,244,770
2	SUPN	Supernus Pharmaceuticals, Inc.	142,182	$7,349,387
3	AMRX	Amneal Pharmaceuticals, Inc. This page	328,003	$4,077,077
4	BCRX	Biocryst Pharmaceuticals Inc	374,016	$3,560,632
5	UTHR	UNITED THERAPEUTICS Corp	4,594	$2,724,150
6	PAHC	Phibro Animal Health Corp	26,750	$1,479,542
7	EBS	Emergent BioSolutions Inc.	156,443	$1,298,476
8	ADCT	ADC Therapeutics SA	64,523	$241,961

All Filings in AMRX

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,077,077	328,003	0.0%	Shares	Sole	2026-05-15
2025-12-31	$4,132,837	328,003	0.0%	Shares	Sole	2026-02-17
2025-09-30	$3,283,310	328,003	+33.8%	Shares	Sole	2025-11-14
2025-06-30	$1,983,627	245,195	+536.5%	Shares	Sole	2025-08-14
2025-03-31	$322,805	38,521	-40.4%	Shares	Sole	2025-05-14
2024-03-31	$391,379	64,584	-4.8%	Shares	Defined	2024-05-07
2023-12-31	$411,734	67,831	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.